mRNA-LNP

Uri Elia1, Yinon Levy1, Hila Cohen1

  • 1Department of Biochemistry and Molecular Genetics, Israel Institute for Biological Research, Ness-Ziona, 76100, Israel.

概括

新的mRNA疫苗结合F1和低响应病毒性抗原 (LcrV) 显示出对肺炎瘟疫的显著保护. 这个平台提供了对抗Yersinia pestis和其他细菌威胁的有希望的策略.